Text Size
39 studies found for:    NIAID | Open Studies | Exclude Unknown

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Recruiting Tdap Vaccine in Post-Partum Women
Conditions: Tetanus;   Diphtheria;   Pertussis
Intervention: Biological: Adacel® Tdap vaccine
22 Recruiting Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
Condition: Respiratory Syncytial Virus Infections
Interventions: Biological: RSV MEDI ΔM2-2 vaccine;   Biological: Placebo vaccine
23 Recruiting Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules
Condition: Rotavirus
Interventions: Biological: RotaTeq®;   Biological: Rotarix®
24 Recruiting Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines WRSs2 and WRSs3
Condition: Shigellosis
Interventions: Other: Placebo;   Biological: WRSs3;   Biological: WRSs2
25 Recruiting Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA-016-00-VP;   Biological: VRCHIVADV014-00-VP
26 Recruiting Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers
Condition: Plague
Interventions: Drug: Placebo;   Biological: Flagellin/F1/V
27 Recruiting Staged Phase I/II Hepatitis C Prophylactic Vaccine
Condition: Hepatitis C
Interventions: Other: Placebo;   Biological: MVA-NSmut;   Biological: AdCh3NSmut1
28 Recruiting Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers
Condition: HIV Infections
Interventions: Biological: RotaTeq vaccine;   Biological: RotaTeq vaccine placebo
29 Recruiting Screening Volunteers for Clinical Trials
Condition: Human Volunteers
Intervention:
30 Recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
31 Recruiting Phase I STEBVax in Healthy Adults
Condition: Staphylococcus Enterotoxin B
Intervention: Biological: STEBVax
32 Recruiting TIV and High Dose TIV in Subjects With Rheumatoid Arthritis
Condition: Influenza
Interventions: Biological: Sanofi Pasteur Fluzone®;   Biological: Sanofi Pasteur Fluzone® High Dose
33 Not yet recruiting Systems Biology of 23-valent Pneumococcal Polysaccharide Vaccine (PNEUMOVAX®23) in the Young and Elderly
Condition: Pneumococcal Infection
Intervention: Biological: PNEUMOVAX
34 Recruiting A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels
Condition: Anthrax
Interventions: Biological: AV7909;   Biological: BioThrax
35 Recruiting VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Conditions: Immunity, Mucosal;   Immune System Processes;   Blood Specimen Collection
Intervention:
36 Recruiting ZOSTAVAX® in Renal Transplant Patients
Condition: Herpes Zoster
Interventions: Drug: Placebo;   Biological: ZOSTAVAX® (Zoster Vaccine Live)
37 Recruiting Immune Memory After Papillomavirus Vaccination
Condition: Healthy Volunteers
Intervention: Drug: quadrivalent HPV vaccine
38 Not yet recruiting Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®
Condition: Smallpox
Intervention: Biological: IMVAMUNE®
39 Recruiting Blood and Plasma Collection For Use in Future H1N1 (Swine Flu) Clinical Trials
Condition: Influenza A Subtype H5N1 Infection
Intervention: Biological: Collection of Anti-Influenza A/H1N1 Immune Plasma
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page
† Indicates status has not been verified in more than two years